Gerald F. Meyer, Consultant
Former Deputy Director of FDA's
Center for Drug Evaluation & Research
"I have audited the drug safety operations of Sentrx, and my view is more than positive. Frankly, I would recommend Sentrx over other companies even if they didn't offer an economic advantage. They have a proven track record and a good reputation. I have also met with a number of their senior staff, including their CEO, CIO and Executive Director of Quality Standards, and have considerable respect for them. I highly recommend Sentrx to any company seeking assistance with adverse event processing or risk management programs."
|